STRIVE/VU.2 | NCT06358469

Primary Objective - To estimate the 3-year local recurrence rates in patients with HPV-A and HPV-I VSCC surgically managed based on dVIN/p53 status and tumour margin clearance.

STRIVE/VU.2 | NCT063584692026-02-09T15:45:53+11:00

EN.10/TAPER | NCT05640999

The primary objective of this study is to estimate the rate of pelvic recurrence at 3 years in patients who are treated with de-escalated adjuvant treatment directed by tumour molecular status.

EN.10/TAPER | NCT056409992024-07-09T16:59:38+10:00
Go to Top